NCT04058704 2019-08-15
SMART
Betta Pharmaceuticals Co., Ltd.
Phase 3 Unknown
Clinical Trials
7 trialsNCT02726568 2019-02-19
High Dose Icotinib With Sequential SRS For NSCLC Patients Harboring EGFR Mutation With Brain Metastases
Betta Pharmaceuticals Co., Ltd.
Phase 2 Unknown
NCT03754530 2018-11-27
Icotinib Combined With Radiation Therapy For NSCLC Patients With Brain Metastases and EGFR Mutation
Betta Pharmaceuticals Co., Ltd.
Phase 2 Unknown
NCT01724801 2017-03-01
BRAIN
Guangdong Association of Clinical Trials
Phase 3 Completed
NCT01514877 2014-07-23
Icotinib Combined With Whole Brain Radiotherapy in Treating Multiple Brain Metastases From Non-Small Cell Lung Cancer
Zhejiang Cancer Hospital
Phase 2 Completed
NCT01516983 2014-02-17
Icotinib Combined With WBRT For NSCLC Patients With Brain Metastases and EGFR Mutation
Betta Pharmaceuticals Co., Ltd.
Phase 1/2 Completed
NCT01688713 2012-09-20
Phase II Trial of Double Dose of Icotinib in Treating Brain Metastases From Non-small Cell Lung Cancer
Zhejiang Cancer Hospital
Phase 2 Unknown